Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
05/31/2001 | WO1999062923A3 Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
05/31/2001 | WO1999028462A9 Polypeptides and nucleic acids encoding the same |
05/30/2001 | EP1102863A1 Mutations in and genomic structure of herg - a long qt syndrome gene |
05/30/2001 | EP1102862A1 Antisense oligonucleotides targeted to il-15 |
05/30/2001 | EP1102842A2 Antisense oligonucleotides for the inhibition of vegf expression |
05/30/2001 | EP1102787A1 2'-o-aminoethyloxyethyl-modified oligonucleotides |
05/30/2001 | EP1102786A2 Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments |
05/30/2001 | EP1102785A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES |
05/30/2001 | EP1102784A1 A compound containing a labile disulfide bond |
05/30/2001 | EP1102783A1 Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom |
05/30/2001 | EP1102781A1 New cofactors for methyltransferases |
05/30/2001 | EP0920526A4 Covalent joining of dna strands to rna strands catalyzed by vaccinia topoisomerase |
05/30/2001 | EP0662093B1 Hiv immunotherapeutics |
05/30/2001 | EP0620822B1 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system |
05/30/2001 | CN1297452A Modified factor VIII |
05/30/2001 | CN1296976A Polypeptide-human epidermal growth factor receptor protein 25 and polynucleotide for coding said polypeptide |
05/30/2001 | CN1296972A Polypeptide-human myosin heavy chain 74 and polynucleotide for coding said polypeptide |
05/30/2001 | CN1296971A Polypeptide-huntingtin protein interactive protein 65 and polynucleotide for coding said polypeptide |
05/30/2001 | CN1296969A Polypeptide-human X chromosome linked gene expression protein 14 and polynucleotide for coding said polypeptide |
05/30/2001 | CN1296965A Polypeptide-human fibrous growth factor receptor 46 and polynucleotide for coding said polypeptide |
05/30/2001 | CN1296963A Polypeptide-human vascular epithelium cadherin 54 and polynucleotide for coding said polypeptide |
05/30/2001 | CN1296961A Polypeptide-human CDC4 analogous protein 13 and polynucleotide for coding said polypeptide |
05/30/2001 | CN1296960A Polypeptide-human CCR4 related protein 31 and polynucleotide for coding said polypeptide |
05/30/2001 | CN1296958A Polypeptide-human G protein 44 and polynucleotide for coding said polypeptide |
05/30/2001 | CN1296955A Human susceptible protein and its coding sequence |
05/30/2001 | CN1296954A Human membrane protein containing C2 structural domain and its coding sequence |
05/30/2001 | CN1296952A Polypeptide-complement receptor 222 and polynucleotide for coding said polypeptide |
05/30/2001 | CN1066486C Riboflavinover producing strains of bacteria |
05/30/2001 | CN1066456C Oligonucleotides having 2'-ether groups |
05/29/2001 | US6239273 Printing molecular library arrays |
05/29/2001 | US6239272 Oligonucleotide having one or more modified nucleotides of defined structure; antisense agents; ribozymes |
05/29/2001 | US6239271 Solid matrix with immoblized intercalator capable of binding nucleic acid, another intercalator which may be labeled with fluorophore, and nucleic acid probe labeled with lanthanide or fluorophore; time resolved fluorescence hybridization |
05/29/2001 | US6239265 Oligonucleotides having chiral phosphorus linkages |
05/29/2001 | US6239256 Isolated muteins of proteins SCP-1, and compositions containing the mutein |
05/29/2001 | US6239159 Nucleoside analogues |
05/29/2001 | US6239116 Immunostimulatory nucleic acid molecules |
05/29/2001 | US6238927 Hybridizing probe to tether nucleic acid which has been immobilized to electrophoretic polymeric medium, migrating test nucleic acid through medium and hybridizing with probe causing displacement of tether, detecting probe-target hybrid |
05/29/2001 | US6238921 Antisense oligonucleotide modulation of human mdm2 expression |
05/29/2001 | US6238898 Hydroperoxide lyases |
05/29/2001 | US6238884 End selection in directed evolution |
05/29/2001 | US6238875 Immunoassay diagnosis of chronic lymphocytic leukemia in humans by detecting and quantitating gene expression of effector cell protease receptors on cd5 positive sample cells |
05/29/2001 | US6238870 Single stranded nucleic acid labeled with electron transfer moiety and attached to electrode by a three-dimensional polymer matrix; bioconductors and diagnostic probes |
05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
05/29/2001 | US6238624 A self-addressable, self-assembling microelectronic device is designed and fabricated to actively carry out and control multi-step and multiplex molecular biological reactions in microscopic formats. |
05/29/2001 | CA2325278A1 Nucleic acid-immobilized substrate |
05/29/2001 | CA2171638C The semaphorin gene family |
05/29/2001 | CA2127530C Metal complexes of water soluble texaphyrins |
05/25/2001 | WO2001037191A2 Method for manipulating protein or dna sequence data (in order to generate complementary peptide ligands) |
05/25/2001 | WO2001036677A1 Development of method for screening physiologically active pyrrole imidazole derivative |
05/25/2001 | WO2001036585A1 Sequence tag microarray and method for detection of multiple proteins through dna methods |
05/25/2001 | WO2001036473A2 Human g protein-coupled receptors |
05/25/2001 | WO2001036441A1 Antisense modulation of src-3 expression |
05/25/2001 | WO2001036439A2 Method for constructing oligodesoxyribonucleotide binomial libraries with codon mutagenized using desoxynucleoside-phosphoramitides |
05/25/2001 | WO2001036086A1 Method for producing finished chemical surfaces |
05/25/2001 | CA2391999A1 Method for constructing oligodesoxyribonucleotide binomial libraries with codon mutagenized using desoxynucleoside-phosphoramitides |
05/25/2001 | CA2388865A1 Novel g protein-coupled receptors |
05/23/2001 | EP1100973A1 Oligomers which inhibit expression of collagen genes |
05/23/2001 | EP1100972A1 Reversible inhibiting probes |
05/23/2001 | EP1100894A2 Short oligonucleotides for the inhibition of vegf expression |
05/23/2001 | EP1100889A1 Micellar systems |
05/23/2001 | EP1100886A1 Tumor necrosis factor-gamma |
05/23/2001 | EP1100880A2 Urate oxidase |
05/23/2001 | EP1100815A1 Protease susceptibility ii |
05/23/2001 | EP1100809A1 Rna targeted 2'-modified oligonucleotides that are conformationally preorganized |
05/23/2001 | EP1100807A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
05/23/2001 | EP0815259B1 Modulation of the binding properties of nucleic acid binding partners |
05/23/2001 | CN1296014A Novel human growth arrestin and coding sequence thereof |
05/22/2001 | US6235887 Measurement, calibration of oligonucleotide binding to nucleic acids |
05/22/2001 | US6235886 Methods of synthesis and use |
05/22/2001 | US6235885 Central nervous system disorders |
05/22/2001 | US6235723 Antisense oligonucleotide modulation of human protein kinase C-δ expression |
05/22/2001 | US6235502 Methods for selectively isolating DNA using rolling circle amplification |
05/22/2001 | US6235475 Generating nucleotide sequence probes; generate nucleotide sequences, compare to library of nucleotide sequences, retain and synthesize preferential nucleotide sequences |
05/22/2001 | US6235470 Detection of neoplasia by analysis of saliva |
05/22/2001 | US6235266 Dinucleotides useful for the treatment of lung disease |
05/17/2001 | WO2001034845A1 Method for quantitating oligonucleotides |
05/17/2001 | WO2001034827A1 Antisense modulation of rank expression |
05/17/2001 | WO2001034765A1 Methods and apparatus for the electronic, homogeneous assembly and fabrication of devices |
05/17/2001 | WO2001034624A1 Methods for identifying compounds that affect rna/rna binding protein interactions |
05/17/2001 | WO2001034620A2 Method and device for producing oligomers and arrays of oligomers and the use of said device |
05/17/2001 | WO2001034619A1 2-aminopurine derivatives |
05/17/2001 | WO2001034207A1 Gene carriers |
05/17/2001 | WO2001021635A3 Method for electrochemically detecting sequence-specific nucleic acid-oligomer hybridisation events |
05/17/2001 | WO2001007602A3 Oligonucleotides for inhibiting the expression of human eg5 |
05/17/2001 | WO2001002593A3 Control of gene expression in eukaryotic cells |
05/17/2001 | WO2000075306A3 Method for producing double stranded polynucleotides |
05/17/2001 | WO1999044620A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
05/17/2001 | CA2391004A1 Method for quantitating oligonucleotides |
05/17/2001 | CA2390233A1 2-aminopurine derivatives |
05/17/2001 | CA2382348A1 Methods for identifying compounds that affect rna/rna binding protein interactions |
05/16/2001 | EP1098990A1 Blocked-polymerase polynucleotide immunoassay method and kit |
05/16/2001 | EP1098966A1 Methods for purifying nucleic acids |
05/16/2001 | EP1023310A4 Improved synthesis of sulfurized oligonucleotides |
05/16/2001 | EP0927270A4 Lyophilization of cultured human cells to preserve rna and dna |
05/16/2001 | EP0753009B1 Malaria peptides |
05/16/2001 | EP0643721B1 Method of synthesizing sulfurized oligonucleotide analogs |
05/16/2001 | CN1295611A Substrates for immobilizing and amplifying DNA DNA-immobilized chips having DNA immobilized on the substrates, and method for amplifying DNA |
05/16/2001 | CN1295078A Antisense thio-oligonucleic acid of target protein kinase C-alpha and its medicine composition and application in treating cancer |
05/16/2001 | CN1065873C Decorative primer |
05/15/2001 | US6232465 Nucleotide 5'-triphosphate having a removable blocking moiety protecting the 3' position and linked to the 3' carbon which is a hydrocarbyl, so a single phosphodiester linkage is formed between the initiating substrate and 5' nucleotide |